Views & Analysis | Perspectives on pharma industry issues

Patients

Older couple high five each other on bicycles at top of hill

The strategic opportunity: Owning the behaviour layer

Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Interview Hakim Yadi and Luba Greenwood at LSX 2024

LSX 2024 - Luba Greenwood and Hakim Yadi

High-profile digital health investor Luba Greenwood recently announced that she’s joined as Chair of the Board at Closed Loop Medicine, a company applying machine learning to precision drug

Digital

Changing Faces – Digital and supplier hires for September 20...

September was a significant month for the companies that support the life sciences industry like CROs, CDMOs, and suppliers, as well as digital health companies.

R&D

Merger and acquisition visual concept with buildings and jigsaw

Closed and Collaborative: Mergers, acquisitions, and partner...

As we head further into H2, a final look back to the summer’s industry mergers and acquisiti

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Digital

Sponsored

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.